Ligand validation:8BZ7

TRH: 2'-DEOXY-THYMIDINE-BETA-L-RHAMNOSE

TRH is a Ligand Of Interest in 8BZ7 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8BZ7_TRH_C_701	56%	69%	0.16	0.933	0.34	0.83	-	4	0	0	100%	1
8BZ7_TRH_B_701	48%	69%	0.176	0.918	0.39	0.78	-	2	0	0	100%	1
8BZ7_TRH_F_701	46%	73%	0.165	0.899	0.37	0.68	-	-	1	0	100%	1
8BZ7_TRH_D_701	45%	79%	0.18	0.912	0.34	0.51	-	-	2	0	100%	1
8BZ7_TRH_A_701	37%	77%	0.188	0.884	0.35	0.55	-	-	2	0	100%	1
8BZ7_TRH_E_701	24%	81%	0.24	0.871	0.33	0.49	-	-	0	0	100%	1
8BZ8_TRH_D_702	59%	84%	0.167	0.951	0.32	0.44	-	-	1	0	100%	1
4J7G_TRH_B_501	99%	21%	0.045	0.983	1.23	2.07	3	15	0	0	100%	1
6N0U_TRH_A_500	96%	51%	0.074	0.983	0.39	1.49	-	2	0	0	100%	1
5IFY_TRH_B_500	96%	60%	0.077	0.985	0.45	1.06	1	1	0	0	100%	1
5XVR_TRH_A_401	94%	24%	0.076	0.976	0.97	2.09	2	9	0	0	100%	1
4J7H_TRH_A_502	89%	22%	0.076	0.954	1.36	1.89	6	15	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.